Publication | Open Access
Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease
135
Citations
20
References
2012
Year
Molecular PharmacologyNeurodegenerative DiseasesMolecular NeuroscienceAlzheimer's DiseaseBiochemistryMedicineNeuropharmacologyNeuroprotectionNeuroscienceAging-associated DiseasePharmacologyMouse ModelSocial Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1